Add like
Add dislike
Add to saved papers

The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population.

OBJECTIVES: Identification of the high risk alleles, genotypes and haplotypes of the human leukocyte antigens (HLA) in different populations is beneficial for understanding their roles in type 1 diabetes (T1D) pathogenesis and intervention practices. This study aimed to identify T1D-associated HLA gene alleles in the Omani population.

METHODS: The present case-control study included 73 diabetic seropositive children (mean age 9.08 ± 3.27 years) attending the paediatric clinic at Sultan Qaboos University Hospital in Muscat, Oman, and 110 healthy controls. HLA-A , -B , -C , -DRB1 and -DQB1 genes were genotyped using a sequence-specific primer polymerase chain reaction (SSP-PCR).

RESULTS: Two HLA class I alleles ( B*08 , B*58 ) and three class II alleles ( DQB1*02 , DRB1*03 and DRB1*04 ) were associated with T1D susceptibility, while one class I ( B*51 ) and three class II ( DQB1*05 , DQB1*06 and DRB1*16 ) alleles were associated with T1D protection. HLA-DRB1*03 and DQB1*02 alleles showed the strongest risk association among all alleles. Six DRB1 residues (E9 , S11 , S13 , Y30 , V70 and K71 ) were significantly associated with T1D susceptibility. Heterozygous genotypes, HLA-DRB1*03 / *04 and DQB1*02 / *03 were significantly associated with T1D susceptibility ( P <0.0001, odds ratio [OR] = 63.21 and P = 0.02, OR = 3.63, respectively). Furthermore, a significant combined action of DRB1*03 - DQB1*02 haplotype in T1D risk ( P = 0.000176, OR = 15) and DRB1*16 - DQB1*05 haplotype in protection ( P = 0.0312, OR = 0.48) was detected.

CONCLUSION: Known HLA class II gene alleles are associated with T1D in Omani children.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app